ONAMI | Siva Kolluri


Siva Kolluri

Assistant Professor, Cancer Biology, Oregon State University


Safer Nanomaterials and Nanomanufacturing


Siva Kolluri received his undergraduate degree with honors in Pharmacy from Birla Institute of Technology and Science, Pilani, India and Master of Technology (Bio-technology) degree from Jadavpur University, Calcutta, India. He worked in biotech industry for about five years with Indian Vaccines Corporation, New Delhi, India and Pasteur Merieux Connaught Serum et Vaccins (currently Aventis Pharma), Lyon, France.  He received his Ph. D. from The Institute of Genetics, Forchungszentrum Karlsruhe with Dr. Martin Goettlicher.

Dr. Kolluri did postdoctoral work with Dr. Xiao-kun Zhang at the Burnham Institute for Medical Research (BIMR), San Diego, California with the support of a fellowship from Department of Defense Breast Cancer Research Program. He was promoted to Staff Scientist and then to Research Assistant Professor at BIMR and was supported by a New Investigator Award from California Tobacco Related Disease Research Program. He joined Oregon State University Department of Environmental and Molecular Toxicology as a tenure-track faculty in 2006.

Recent Publications

    Kolluri, S.K., Zhu, X., Zhou, X., Lin, B., Chen Y., Reed, J.C., Satterthwait, A.C., and Zhang, XK. A Short Nuclear Orphan Receptor Nur77-derived Peptide Converts Bcl-2 from a Protector to a Killer of Cancer Cells (in review).
    Kolluri SK, Corr M, James SY, Bernasconi M, Lu D, Liu W, Cottam HB, Leoni LM, Carson DA, Zhang XK. The Renantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc Natl Acad Sci U S A. 2005 Feb 15,102(7):2525-30. Epub 2005 Feb 7.

Visit this researcher's website HERE




Additional Links